Birla Cotsyn India Ltd
Birla Cotsyn (India) is engaged in the business of cotton and synthetic yarn manufacturing, weaving of grey fabrics, ginning and pressing of cotton bales, and fabric trading. The Company's segments include Textiles and Trading in Fabrics.
- Market Cap ₹ 34.9 Cr.
- Current Price ₹ 0.13
- High / Low ₹ /
- Stock P/E
- Book Value ₹ 0.13
- Dividend Yield 0.00 %
- ROCE -5.26 %
- ROE %
- Face Value ₹ 1.00
Pros
- Company has reduced debt.
- Stock is trading at 0.98 times its book value
Cons
- Company has low interest coverage ratio.
- Company might be capitalizing the interest cost
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Consumer Discretionary Textiles Textiles & Apparels Other Textile Products
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
Mar 2009 | Mar 2010 | Mar 2011 | Mar 2012 | Jun 2013 15m | Mar 2014 9m | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
194 | 344 | 540 | 759 | 344 | 93 | 112 | 99 | 96 | 103 | 0 | 0 | |
186 | 318 | 488 | 706 | 433 | 108 | 115 | 101 | 107 | 103 | 1 | 4 | |
Operating Profit | 7 | 26 | 52 | 53 | -89 | -15 | -3 | -2 | -11 | 0 | -1 | -4 |
OPM % | 4% | 8% | 10% | 7% | -26% | -16% | -3% | -2% | -11% | 0% | ||
6 | 10 | 1 | 6 | 4 | 4 | -94 | 1 | 10 | 10 | 0 | -205 | |
Interest | 5 | 19 | 31 | 40 | 54 | 36 | 53 | 63 | 73 | 86 | 0 | 0 |
Depreciation | 5 | 5 | 8 | 10 | 12 | 8 | 14 | 14 | 14 | 14 | 6 | 6 |
Profit before tax | 3 | 12 | 14 | 9 | -151 | -55 | -164 | -77 | -88 | -90 | -7 | -215 |
Tax % | 36% | 35% | 23% | 79% | -7% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
2 | 8 | 11 | 2 | -140 | -55 | -164 | -77 | -88 | -90 | -7 | -215 | |
EPS in Rs | 0.02 | 0.03 | 0.04 | 0.01 | -0.52 | -0.20 | -0.62 | -0.29 | -0.33 | -0.33 | -0.03 | -0.80 |
Dividend Payout % | 55% | 127% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
Compounded Sales Growth | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | % |
TTM: | % |
Compounded Profit Growth | |
---|---|
10 Years: | 6% |
5 Years: | % |
3 Years: | % |
TTM: | -35% |
Stock Price CAGR | |
---|---|
10 Years: | 3% |
5 Years: | 5% |
3 Years: | % |
1 Year: | % |
Return on Equity | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | % |
Last Year: | % |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
Mar 2009 | Mar 2010 | Mar 2011 | Mar 2012 | Jun 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Equity Capital | 117 | 213 | 261 | 267 | 267 | 267 | 267 | 267 | 267 | 269 | 269 | 26 |
Reserves | 55 | 67 | 33 | 49 | -87 | -132 | -292 | -366 | -454 | -543 | -658 | 9 |
157 | 204 | 264 | 261 | 259 | 270 | 269 | 260 | 259 | 251 | 692 | 22 | |
39 | 52 | 95 | 176 | 82 | 101 | 148 | 217 | 292 | 374 | 37 | 11 | |
Total Liabilities | 369 | 537 | 652 | 753 | 521 | 505 | 392 | 378 | 364 | 351 | 339 | 69 |
150 | 169 | 190 | 184 | 174 | 167 | 169 | 156 | 142 | 129 | 66 | 60 | |
CWIP | 134 | 124 | 8 | 18 | 20 | 20 | 0 | 0 | 0 | 0 | 0 | 0 |
Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
85 | 243 | 454 | 551 | 327 | 318 | 223 | 222 | 221 | 222 | 273 | 9 | |
Total Assets | 369 | 537 | 652 | 753 | 521 | 505 | 392 | 378 | 364 | 351 | 339 | 69 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
Mar 2009 | Mar 2010 | Mar 2011 | Mar 2012 | Jun 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
-8 | -10 | -34 | -51 | 80 | -3 | 1 | 1 | -2 | 5 | -1 | -205 | |
-159 | -15 | -6 | -12 | -10 | -3 | 5 | 6 | -0 | -1 | 0 | 242 | |
163 | 141 | 22 | -34 | -67 | 2 | -6 | -4 | -0 | -3 | 0 | -30 | |
Net Cash Flow | -4 | 116 | -18 | -98 | 3 | -4 | -0 | 3 | -3 | 1 | -1 | 7 |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
Mar 2009 | Mar 2010 | Mar 2011 | Mar 2012 | Jun 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Debtor Days | 52 | 76 | 81 | 119 | 14 | 2 | 1 | 1 | 1 | 1 | ||
Inventory Days | 43 | 27 | 55 | 21 | 20 | 58 | 38 | 55 | 40 | 36 | ||
Days Payable | 60 | 30 | 66 | 84 | 38 | 126 | 67 | 89 | 82 | 69 | ||
Cash Conversion Cycle | 35 | 74 | 70 | 56 | -4 | -66 | -28 | -33 | -41 | -32 | ||
Working Capital Days | 86 | 82 | 64 | 51 | -86 | -464 | -755 | -1,084 | -1,404 | -1,592 | ||
ROCE % | 3% | 8% | 9% | 8% | -19% | -4% | -7% | -13% | -13% | -5% |
Documents
Announcements
- Announcement under Regulation 30 (LODR)-Newspaper Publication 31 May
-
Announcement under Regulation 30 (LODR)-Meeting Updates
30 May - NCLT approves compromise scheme; INR 3 Cr working capital infusion; multiple years' financials approved.
-
Announcement under Regulation 30 (LODR)-Meeting Updates
30 May - NCLT approves compromise scheme; working capital infusion of INR 3 Cr; financial results recorded.
-
Announcement under Regulation 30 (LODR)-Meeting Updates
30 May - NCLT approved composite insolvency scheme; financials recorded; legal action planned for CIRP period claims; INR 3 Cr working capital infusion.
-
Announcement under Regulation 30 (LODR)-Meeting Updates
30 May - NCLT approved compromise scheme; financials recorded; INR 3 Cr working capital infusion approved.
Annual reports
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from nse
-
Financial Year 2012
from bse
-
Financial Year 2011
from bse
-
Financial Year 2010
from bse
-
Financial Year 2010
from nse